Clinical Trial Update: Use of Exparel for Postoperative Analgesia Following Bariatric Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating Exparel for postoperative analgesia after bariatric surgery; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain Management After Bariatric Surgery

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: McMaster University | Conditions: Post Operative Pain | Phase 4 | Status: UNKNOWN